<?xml version="1.0" encoding="UTF-8"?>
<p>The overwhelming death toll from COVID-19 has sparked a myriad of projects to identify drugs that can be repurposed on a fast track to for special treatment of patients with severe disease.
 <xref rid="b6-rmmj-11-3-e0027" ref-type="bibr">6</xref> In the meantime, the only drug that has shown some beneficial results in a double-blind randomized clinical trial compared to placebo is the antiviral remdesivir, which has been approved by the US Food and Drug Administration and other regulatory institutions.
 <xref rid="b82-rmmj-11-3-e0027" ref-type="bibr">82</xref>
</p>
